Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to analyze and identify pre-, intra-, and post- operative parameters that predict Steal-Syndrome with distal malperfusion after Arterio-Venous Fistulas (AVF) as primary endpoint. Secondary endpoints are pre-, intra-, and post- operative parameters that predict patency and fistula maturation.
| Condition |
|---|
|
Chronic Kidney Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial) |
- Steal-Syndrome [ Time Frame: 1 year ] [ Designated as safety issue: No ]Steal Syndrome as defined according to the guidelines of the Society of Vascular Surgery (SVS): Asymptomatic (pulse deficits, doppler signal attenuation, and distal flow reversal) Mild Ischemia: slight coldness and numbness that occurs only during dialysis, may be self-limited, and may resosolve without treatment, and Severe Ischemia: Can be permanent and may be associated with constant pain, severe numbness, digital cyanosis or gangrene, finger contracture, or amputation of a digit hand or forearm. Standard assessment for steal syndrom at 5-10 days, 4-6 weeks, 6 months, and 1 year.
- Time to fistula maturation [ Time Frame: 1 year ] [ Designated as safety issue: No ]Time between fistula creation and time to clinical fistula maturation, standard assessment of fistula maturation at 5-10 days, 4-6 weeks, 6 months, and 1 year
- Fistula patency [ Time Frame: 1 year ] [ Designated as safety issue: No ]Time between fistula creation and time to first intervention to restore fistula function (operation, endovascular procedure)
| Estimated Enrollment: | 500 |
| Study Start Date: | September 2011 |
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Fistula patients
Consecutive patients with autogenous, brachio-cephalic, brachio-basilic or brachio-brachial arterio-venous fistula creation for hemodialysis
|
Detailed Description:
This is a prospective study where the research team will acquire data from the patients after they have signed the informed consent form. Data will be collected before, during and after the Arterio-Venous Fistula(AVF)placement, and during follow-up at predefined time intervals:Pre-Operative, Intra-operative, Post-operative, 5-10 days, 4-6 Weeks, 6 Months, and 1 year. These parameters include Digital Brachial Index (DBI) (assessed by Doppler derived brachial artery blood pressure/ photoplethysmographically derived finger blood pressure), flow and pulsatility measurements (derived by duplex ultrasound and pulse volume recording). Assessment of flow and pulsatility will be performed in the artery proximal and distal to the AVF, as well as in the venous outflow. In addition, Demographic parameters and patient comorbidities will be acquired and procedure specific parameters (e.g. location of the fistula) will be documented. During each follow up, clinical evaluation for Steal-Syndrome will be conducted. Steal-Syndrome was defined according to the guidelines of the Society of Vascular Surgery (SVS): Asymptomatic (pulse deficits, doppler signal attenuation, and distal flow reversal) Mild Ischemia: slight coldness and numbness that occurs only during dialysis, may be self-limited, and may resosolve without treatment, and Severe Ischemia: Can be permanent and may be associated with constant pain, severe numbness, digital cyanosis or gangrene, finger contracture, or amputation of a digit hand or forearm. The necessity for and type of re-intervention at the AVF will be documented. Acquisition of data will in no way change the standard of care used in these patients / operations.
Data analysis will be performed after enrolment of 100, 250 and 500 patients.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients selected for this protocol must have the necessity to undergo surgery to receive an Arterio-Venos Fistula (AVF) for hemodialysis in either arm.
Inclusion Criteria:
- Patients 18 years of age
- Autogenous, brachio-cephalic, brachio-basilic or brachio-brachial Arterio- Venous Fistula creation for hemodialysis
- General preoperative requirements for this surgery passed
- Patients willing to adhere to the follow-up
- Patients able to understand and provide informed consent
Exclusion Criteria:
- Less than 18 years of age
- Patient is unable or unwilling to provide consent
- Prosthetic graft creation
- Creation of a radio-cephalic AV-Fistula other than described in the inclusion criteria
Contacts and Locations| Contact: Athanassios Tsoukas, M.D. | 305-274-2030 | tsoukas@pol.net |
| Contact: Heiko Uthoff, M.D. | 786-246-6068 | heikou@baptisthealth.net |
| United States, Florida | |
| Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute | Recruiting |
| Miami, Florida, United States, 33176 | |
| Contact: Athanassios Tsoukas, M.D. 305-274-2030 tsoukas@pol.net | |
| Contact: Heiko Uthoff, M.D. 786-246-6068 heikou@baptisthealth.net | |
| Principal Investigator: Athanassios Tsoukas, M.D. | |
| Principal Investigator: Heiko Uthoff, M.D. | |
| Sub-Investigator: James Benenati, M.D. | |
| Sub-Investigator: Barry T Katzen, M.D. | |
| Sub-Investigator: Dillon Arango, MD Candidate | |
| Principal Investigator: Philipp Geisbuesch, MD | |
| Principal Investigator: | Athanassios Tsoukas, MD | Baptist Hospital Miami, BCVI |
| Principal Investigator: | Heiko Uthoff, MD | Baptist Hospital Miami, BCVI |
| Principal Investigator: | Philipp Geisbuesch, MD | Baptist Hospital Miami, BCVI |
More Information
No publications provided
| Responsible Party: | Margaret Kovacs, Director of Clinical Research, Baptist Hospital of Miami, BCVI, Baptist Hospital of Miami |
| ClinicalTrials.gov Identifier: | NCT01468506 History of Changes |
| Other Study ID Numbers: | UPSAC version 17 Jul 2011 |
| Study First Received: | November 3, 2011 |
| Last Updated: | July 3, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Baptist Health South Florida:
|
Chronic Kidney Disease arteriovenous fistula |
Additional relevant MeSH terms:
|
Arteriovenous Fistula Fistula Kidney Diseases Renal Insufficiency, Chronic Kidney Failure, Chronic Arteriovenous Malformations Vascular Malformations Cardiovascular Abnormalities |
Cardiovascular Diseases Vascular Fistula Vascular Diseases Congenital Abnormalities Pathological Conditions, Anatomical Urologic Diseases Renal Insufficiency |
ClinicalTrials.gov processed this record on June 18, 2013